The Europe heart transplant market is expected to grow from US$ 3,970.32 million in 2022 to US$ 8,789.67 million by 2030. It is estimated to grow at a CAGR of 10.4% from 2022 to 2030.
In Europe, efforts to raise awareness about heart transplantation include educational campaigns, collaboration between healthcare providers and organ procurement organizations, legislative initiatives, and public advocacy from medical professionals and organizations. These efforts aim to inform the public about the critical need for heart donors, address concerns or misconceptions, and encourage individuals to register as organ donors. Additionally, advancements in medical technology and surgical techniques have contributed to the success and viability of heart transplantation, further highlighting the importance of organ donation in saving lives. As a result, there has been an increasing acceptance and understanding of heart transplantation as a treatment option for end-stage heart failure within European countries.
The Europe heart transplant market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global heart transplant market and is estimated to register a notable CAGR during 2022-2030. The prevalence of cardiovascular diseases, leading to heart failure, contributes to the market growth in the region. Germany is an attractive market due to its consistent growth and innovative approach toward the healthcare sector. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 474 billion in 2021. The rising geriatric population with the increasing prevalence of chronic disease propels the heart transplant market growth in the country. With the growing age, many organs start to malfunction or become dysfunctional giving rise to organ transplantation procedures. Further, according to the WHO, ~4 in 10 deaths in Germany result from behavioural risk factors, including dietary risks, smoking, alcohol consumption, and low physical activity. In 2021, nearly 19% adults were obese in Germany. Obesity gives rise to various other health-related problems. Thus, public health issues such as obesity and overweight, resulting in chronic health disorders, can fuel the demand for organ transplantation procedures in Germany.
There is a gap between organ demand and organ donations in Germany. According to the German Foundation for Organ Transplantation (DSO), a total of 2,905 organs were donated post-mortem in 2021, in contrast to the need for 8,730 organs. Therefore, organ transplantation procedures are expected to grow in the coming years in the country significantly.
Strategic insights for the Europe Heart Transplant provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 3,970.32 Million |
Market Size by 2030 | US$ 8,789.67 Million |
Global CAGR (2022 - 2030) | 10.4% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Surgery Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Heart Transplant refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe heart transplant market is segmented into surgery type, type, end user, and country.
Based on surgery type, the Europe heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Europe heart transplant market in 2022.
In terms of type, the Europe heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Europe heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Europe heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Europe heart transplant market in 2022.
Based on country, the Europe heart transplant market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany dominated the Europe heart transplant market in 2022.
Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the Europe heart transplant market.
1. Terumo Corp
2. Abbott Laboratories
3. SynCardia Systems LLC
4. BioVentrix Inc
5. Berlin Heart GmbH
6. LivaNova Plc
7. Calon Cardio-Technology Ltd
The Europe Heart Transplant Market is valued at US$ 3,970.32 Million in 2022, it is projected to reach US$ 8,789.67 Million by 2030.
As per our report Europe Heart Transplant Market, the market size is valued at US$ 3,970.32 Million in 2022, projecting it to reach US$ 8,789.67 Million by 2030. This translates to a CAGR of approximately 10.4% during the forecast period.
The Europe Heart Transplant Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Heart Transplant Market report:
The Europe Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Heart Transplant Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.